$8.05
12.12% yesterday
NYSE, Sep 18, 09:48 pm CET
ISIN
CA0717341071
Symbol
BHC
Sector
Industry

Bausch Health Companies Inc. Stock price

$8.02
+2.27 39.48% 1M
-1.36 14.50% 6M
+0.00 0.00% YTD
-0.35 4.18% 1Y
-18.09 69.28% 3Y
-15.17 65.42% 5Y
-112.50 93.35% 10Y
NYSE, Closing price Wed, Sep 18 2024
+0.84 11.70%
ISIN
CA0717341071
Symbol
BHC
Sector
Industry

Key metrics

Market capitalization $2.94b
Enterprise Value $24.93b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 27.31
EV/Sales (TTM) EV/Sales 2.71
P/S ratio (TTM) P/S ratio 0.32
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 10.20%
Revenue (TTM) Revenue $9.20b
EBIT (operating result TTM) EBIT $1.72b
Free Cash Flow (TTM) Free Cash Flow $912.91m
Cash position $623.00m
EPS (TTM) EPS $-1.29
P/E forward 24.13
P/S forward 0.28
EV/Sales forward 2.60
Short interest 5.84%
Show more

Is Bausch Health Companies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Bausch Health Companies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Bausch Health Companies Inc. forecast:

1x Buy
14%
4x Hold
57%
2x Sell
29%

Analyst Opinions

7 Analysts have issued a Bausch Health Companies Inc. forecast:

Buy
14%
Hold
57%
Sell
29%

Financial data from Bausch Health Companies Inc.

Dec '23
+/-
%
Net Profit -592 -592
163% 163%
-7%
Depreciation and Amortization 1,264 1,264
9% 9%
14%
Stock Compensation 132 132
5% 5%
2%
Operating Cash Flow 996 996
225% 225%
11%
Investments 272 272
1% 1%
3%
Dividend Paid - -
-
-
Free Cash Flow 781 781
177% 177%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Bausch Health Companies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bausch Health Companies Inc. Stock News

Positive
CNBC
one day ago
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don't think like your typical corporate board, writes Ken Squire of 13D Monitor.
Positive
Market Watch
3 days ago
Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported.
Neutral
Accesswire
8 days ago
LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the approval by Health Canada of PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, a new triple-combination topical prescription treatment for acne vulgaris in patients 12 years of age and older.1 CABTRE...
More Bausch Health Companies Inc. News

Company Profile

Manufactures and markets pharmaceutical products

Head office Canada
CEO Thomas Appio
Employees 20,270
Founded 1994
Website www.bauschhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today